MECHANISMS OF ACQUIRED RESISTANCE TO CETUXIMAB: ROLE OF HER (ErbB) FAMILY MEMBERS

The epidermal growth factor receptor (EGFR) is a central regulator of proliferation and progression in human cancers. Five EGFR inhibitors, two monoclonal antibodies and three TKIs, have recently gained FDA approval in oncology (cetuximab, panitumumab, erlotinib, gefitinib and lapatinib). These stra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wheeler, Deric L., Huang, Shyhmin, Kruser, Tim J., Nechrebecki, Meghan M., Armstrong, Eric A., Benavente, Sergio, Gondi, Vinai, Hsu, Kun-Tai, Harari, Paul M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903615/
https://ncbi.nlm.nih.gov/pubmed/18297114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2008.19
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares